CB
CRL icon

CNB Bank’s Charles River Laboratories CRL Stock Holding History

CNB Bank’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.9K Sell
211
-150
-42% -$26.7K 0.02% 302
2026
Q1 		$62.3K Sell
361
-175
-33% -$32.4K 0.03% 275
2025
Q4 		$107K Sell
536
-243
-31% -$44.1K 0.04% 202
2025
Q3 		$122K Sell
779
-263
-25% -$41.8K 0.05% 202
2025
Q2 		$158K Sell
1,042
-771
-43% -$103K 0.07% 156
2025
Q1 		$273K Sell
1,813
-649
-26% -$109K 0.14% 128
2024
Q4 		$454K Sell
2,462
-240
-9% -$46.2K 0.21% 107
2024
Q3 		$532K Sell
2,702
-153
-5% -$31.8K 0.25% 99
2024
Q2 		$590K Sell
2,855
-123
-4% -$27.9K 0.28% 89
2024
Q1 		$807K Buy
2,978
+16
+0.5% +$3.82K 0.39% 75
2023
Q4 		$700K Buy
2,962
+263
+10% +$51.7K 0.38% 77
2023
Q3 		$529K Buy
2,699
+274
+11% +$56.3K 0.31% 87
2023
Q2 		$510K Buy
2,425
+90
+4% +$17.9K 0.3% 89
2023
Q1 		$471K Buy
2,335
+11
+0.5% +$2.49K 0.29% 90
2022
Q4 		$506K Buy
2,324
+98
+4% +$21.4K 0.32% 85
2022
Q3 		$438K Buy
2,226
+125
+6% +$27K 0.3% 87
2022
Q2 		$449K Buy
2,101
+146
+7% +$35.7K 0.29% 86
2022
Q1 		$556K Buy
1,955
+198
+11% +$61.1K 0.31% 84
2021
Q4 		$662K Buy
1,757
+160
+10% +$62.2K 0.36% 77
2021
Q3 		$660K Buy
1,597
+87
+6% +$36.1K 0.4% 72
2021
Q2 		$559K Buy
1,510
+162
+12% +$54.1K 0.35% 84
2021
Q1 		$390K Buy
1,348
+209
+18% +$58.1K 0.27% 91
2020
Q4 		$284K Buy
1,139
+105
+10% +$25K 0.21% 104
2020
Q3 		$234K Sell
1,034
-74
-7% -$15.4K 0.2% 106
2020
Q2 		$193K Buy
1,108
+54
+5% +$8.62K 0.17% 115
2020
Q1 		$133K Buy
1,054
+784
+290% +$118K 0.14% 145
2019
Q4 		$41K Buy
+270
New +$37.4K 0.03% 236

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

CNB Bank's CRL Position: Q2 2026 in Review

CNB Bank reduced its Charles River Laboratories (CRL) stake by 42% in Q2 2026, selling an estimated $26.7K and leaving 211 shares worth $47.9K. The position accounts for 0.02% of the portfolio, ranked #302.

CNB Bank first reported a position in CRL in Q4 2019 and has held it in 27 quarters since. The position peaked at $807K in Q1 2024. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • CNB Bank held 211 shares of Charles River Laboratories worth $47.9K as of Q2 2026.
  • CNB Bank sold 150 Charles River Laboratories shares in Q2 2026, an estimated $26.7K.
  • Charles River Laboratories made up 0.02% of CNB Bank's portfolio in Q2 2026, its #302 holding.
  • CNB Bank first reported a position in Charles River Laboratories in Q4 2019 and has held it in 27 quarters since.
  • CNB Bank's Charles River Laboratories position peaked at $807K in Q1 2024.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on CNB Bank's 13F filing for Q2 2026, filed 6 Aug 2026.